National Institute of Allergy and Infectious Diseases
Link to NIAID Home Page Link to NIAID Home Page Link to NIH Home Page
NIAID Home Health & Science Research Funding Research News & Events Labs at NIAID About NIAID

VRC
 About the VRC
 Publications
  2009
  2008
  2007
  2006
  2005
  2004
  2003
  2002
  2001
  2000
  1999
 Research Areas


Vaccine Research Center (VRC)

Journal Publications, 2003

The NIH Library provides information about online journal access.

December

Journal of Virology
Immunogenicity of multiple gene and clade human immunodeficiency virus type 1 DNA vaccines.
Kong WP, Huang Y, Yang ZY, Chakrabarti BK, Moodie Z, Nabel GJ.
J Virol. 77(23): 12764-72.

Nature
The gene product Murr1 restricts HIV-1 replication in resting CD4+ lymphocytes.
Ganesh L, Burstein E, Guha-Niyogi A, Louder MK, Mascola JR, Klomp LW, Wijmenga C, Duckett CS, Nabel GJ.
Nature. 426(6968): 853-7.

Blood
Identification and in vitro expansion of CD4+ and CD8+ T cells specific for human neutrophil elastase.
Fujiwara H, El Ouriaghli F, Grube M, Price DA, Rezvani K, Gostick E, Sconocchia G, Melenhorst J, Hensel N, Douek DC, Barrett AJ.
Blood. 2003

November

AIDS
Diverse HIV-1 subtypes and clinical, laboratory and behavioral factors in a recently infected US military cohort.
Brodine SK, Starkey MJ, Shaffer RA, Ito SI, Tasker SA, Barile AJ, Tamminga CL, Stephan KT, Aronson NE, Fraser SL, Wallace MR, Wegner SA, Mascola JR, McCutchan FE.
AIDS. 17(17):2521-27.

Antimicrobial Agents and Chemotherapy
Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.
Budge PJ, Lebowitz J, Graham BS.
Antimicrobial Agents and Chemotherapy. (11):3470-7.

October

Blood
Functional leukemia-associated antigen-specific memory CD8+ T cells exist in healthy individuals and in patients with chronic myelogenous leukemia before and after stem cell transplantation.
Rezvani K, Grube M, Brenchley JM, Sconocchia G, Fujiwara H, Price DA, Gostick E, Yamada K, Melenhorst J, Childs R, Hensel N, Douek DC, Barrett AJ.
Blood. 102 (8) 2892-900

Immunology Letters
Low T cell receptor excision circle levels in patients thymectomized 25-54 years ago.
Storek J, Douek DC, Keesey JC, Boehmer L, Storer B, Maloney DG
Immunol Lett. 89(2-3):91-2.

Journal of Immunological Methods
Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation.
Betts MR, Brenchley JM, Price DA, De Rosa SC, Douek DC, Roederer M, Koup RA.
Journal of Immunological Methods. 281 (1-2):65-78.

Journal of Immunology
Toll-Like Receptor Ligands Modulate Dendritic Cells to Augment Cytomegalovirus- and HIV-1-Specific T Cell Responses.
Lore K, Betts MR, Brenchley JM, Kuruppu J, Khojasteh, Perfetto S, Mario M, Seder RA, Koup RA
J Immunol. 171(8):4320-8.

Journal of Virology
Access of Antibody Molecules to the Conserved Coreceptor Binding Site on Glycoprotein gp120 Is Sterically Restricted on Primary Human Immunodeficiency Virus Type 1.
Labrijn AF, Poignard P, Raja A, Zwick MB, Delgado K, Franti M, Binley J, Vivona V, Grundner C, Huang CC, Venturi M, Petropoulos CJ, Wrin T, Dimitrov DS, Robinson J, Kwong PD, Wyatt RT, Sodroski J, Burton DR.
J Virol. 2003 Oct 1;77(19):10557-10565.

Journal of Virology
Cellular immunity elicited by human immunodeficiency virus type 1/ simian immunodeficiency virus DNA vaccination does not augment the sterile protection afforded by passive infusion of neutralizing antibodies.
Mascola JR, Lewis MG, VanCott TC, Stiegler G, Katinger H, Seaman M, Beaudry K, Barouch DH, Korioth-Schmitz B, Krivulka G, Sambor A, Welcher B, Douek DC, Montefiori DC, Shiver JW, Poignard P, Burton DR, Letvin NL.
J Virol. 77(19):10348-56.

Nature Medicine
Ex vivo identification, isolation and analysis of tumor-cytolytic T cells.
Rubio V, Stuge TB, Singh N, Betts MR, Weber JS, Roederer M, Lee PP.
Nat Med. 2003 Oct 5 [Epub ahead of print]

Virology
Epitope mapping and characterization of a novel CD4-induced human monoclonal antibody capable of neutralizing primary HIV-1 strains.
Xiang S-H, Wang L, Abreu M, Huang C, Kwong PD, Rosenberg E, Robinson JE and Sodroski J.
Virology. 325:124-134.

September

British Journal of Haematology
Early reconstitution of the T-cell repertoire after non-myeloablative peripheral blood stem cell transplantation is from post-thymic T-cell expansion and is unaffected by graft-versus-host disease or mixed chimaerism.
Bahceci E, Epperson D, Douek DC, Melenhorst JJ, Childs RC, Barrett AJ
Br J Haematol. 122(6):934-43.

Infectious Immunology
Coinjection with CpG-containing immunostimulatory oligodeoxynucleotides reduces the pathogenicity of a live vaccine against cutaneous Leishmaniasis but maintains its potency and durability.
Mendez S, Tabbara K, Belkaid Y, Bertholet S, Verthelyi D, Klinman D, Seder RA, Sacks DL.
Infect Immun. 71(9):5121-9.

Journal of Immunology
Prime-boost vaccination with HIV-1 Gag protein and cytosine phosphate guanosine oligodeoxynucleotide, followed by adenovirus, induces sustained and robust humoral and cellular immune responses.
Tritel M, Stoddard AM, Flynn BJ, Darrah PA, Wu CY, Wille U, Shah JA, Huang Y, Xu L, Betts MR, Nabel GJ, Seder RA.
J Immunol. 2003 Sep 1;171(5):2538-47.

Journal of Virology
Ebola virus pathogenesis: implications for vaccines and therapies.
Sullivan N, Yang ZY, Nabel GJ.
J Virol. 2003 Sep;77(18):9733-7.

Journal of Virology
Enhanced mucosal immunoglobulin a response of intranasal adenoviral vector human immunodeficiency virus vaccine and localization in the central nervous system.
Lemiale F, Kong WP, Akyurek LM, Ling X, Huang Y, Chakrabarti BK, Eckhaus M, Nabel GJ.
J Virol. 2003 Sep;77(18):10078-87.

Nature Immunology
Similarities and differences in CD4+ and CD8+ effector and memory T cell generation.
Seder RA, Ahmed R.
Nat Immunol. 4(9):835-42.

Structure
Enhancing Protein Crystallization through Precipitant Synergy.
Majeed S, Ofek G, Belachew A, Huang C, Zhou T, Kwong PD.
Structure (Camb). 2003 Sep;11(9):1061-70.

Virology
Structure-based, Targeted Deglycosylation of HIV-1 gp120 and Effects on Neutralization Sensitivity and Antibody Recognition.
Kock M, Pancera M, Kwong PD, Kolchinsky P, Grundner C, Wang L, Hendrickson WA, Sodroski J and Wyatt R. (2003)
Virology. 313: 387-400.

August

Current Opinion in Immunology
DNA vaccination: the answer to stable, protective T-cell memory?
Kirman JR, Seder RA.
Curr Opin Immunol. 15(4):471-6.

Journal of Immunology Methods
Optimized lymphocyte isolation methods for analysis of chemokine receptor expression.
Berhanu D, Mortari F, De Rosa SC, Roederer M.
J Immunol Methods. 279(1-2):199-207.

Nature
Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates.
Sullivan NJ, Geisbert TW, Geisbert JB, Xu L, Yang ZY, Roederer M, Koup RA, Jahrling PB, Nabel GJ.
Nature. 2003 Aug 7;424(6949):681-4.

July

Cell
Tyrosine sulfation of human antibodies contributes to recognition of the CCR5 binding region of HIV-1 gp120. Choe H, Li W, Wright PL, Vasilieva N, Venturi M, Huang CC, Grundner C, Dorfman T, Zwick MB, Wang L, Rosenberg ES, Kwong PD, Burton DR, Robinson JE, Sodroski JG, Farzan M.
Cell. 2003 Jul 25;114(2):161-70.

Journal of Experimental Medicine
Dendritic Cells Are Responsible for the Capacity of CpG Oligodeoxynucleotides to Act as an Adjuvant for Protective Vaccine Immunity Against Leishmania major in Mice.
Shah JA, Darrah PA, Ambrozak DR, Turon TN, Mendez S, Kirman J, Wu CY, Glaichenhaus N, Seder RA.
J Exp Med. 2003 Jul 21;198(2):281-91.

June

Journal of Clinical Microbiology
Herpesvirus DNA is consistently detected in lungs of patients with idiopathic pulmonary fibrosis.
Tang YW, Johnson JE, Browning PJ, Cruz-Gervis RA, Davis A, Graham BS, Brigham KL, Oates JA Jr, Loyd JE, Stecenko AA.
J Clin Microbiol. 41(6):2633-40

May

Current Molecular Medicine
Defining the protective antibody response for HIV-1.
Mascola JR.
Curr Mol Med. 2003 May;3(3):209-16.

April

Cytometry
Measuring containment of viable infectious cell sorting in high velocity cell sorters
Perfetto SP, DR Ambrozak, RA Koup, and M Roederer
Cytometry. 52A (2): 122-130

Nature Medicine
HIV-1: nature's master of disguise.
Mascola JR, Montefiori DC.
Nat Med. 2003 9(4): 393-4.

Viral Immunology
The complex relationship between respiratory syncytial virus and allergy in lung disease.
Peebles RS Jr, Hashimoto K, Graham BS.
Viral Immunol. 16(1):25-34

Virus Research
Vaccine for AIDS and Ebola virus infection.
Nabel GJ.
Virus Res. 2003 Apr;92(2):213-7. Review.

March

Immunity
Non-pathogenic simian immunodeficiency virus infection of sooty mangabey monkeys is characterized by limited bystander immunopathology and preserved immune regenerative capacity despite chronic high level virus replication.
Silvestri G, DL Sodora, RA Koup, SP O'Neil, HM McClure, SI Staprans, and MB Feinberg.
Immunity. 18 (3): 441-52

Journal of Immunological Methods
Optimized determination of T cell epitope responses
Roederer M, and RA Koup.
J. Immunol. Methods. 274 (1-2): 221-228

Nature
Antibody neutralization and escape by HIV-1.
Wei X, Decker JM, Wang S, Hui H, Kappes JC, Wu X, Salazar-Gonzalez JF, Salazar MG, Kilby JM, Saag MS, Komarova NL, Nowak MA, Hahn BH, Kwong PD, Shaw GM.
Nature. 2003 Mar 20;422(6929):307-12.

February

Journal of Immunology
IL-13 is sufficient for respiratory syncytial virus G glycoprotein-induced eosinophilia after respiratory syncytial virus challenge.
Johnson TR, Parker RA, Johnson JE, Graham BS.
J Immunol. 2003 Feb 15;170(4):2037-45.

Journal of Virology
Role of plasma membrane lipid microdomains in respiratory syncytial virus filament formation.
McCurdy LH, Graham BS.
J Virol. 2003 Feb;77(3):1747-56.

PNAS
Definitive separation of graft-versus-leukemia- and graft-versus-host-specific CD4+ T cells by virtue of their receptor beta loci sequences.
J. Michálek, R. H. Collins, H. P. Durrani, P. Václavková, L. E. Ruff, D. C. Douek, and E. S. Vitetta.
Proc Natl Acad Sci U S A. 2003 Feb 4;100(3):1180-1184.

January

Immunology
T Cell Dynamics in HIV-1 Infection.
Douek DC, Picker LJ, Koup RA.
Annu Rev Immunol. 2003 Jan 8.

Infection and Immunity
Enhanced Immunogenicity to Mycobacterium tuberculosis by Vaccination with an Alphavirus Plasmid Replicon Expressing Antigen 85A
Kirman JR, Turon T, Su H, Li A, Kraus C, Polo JM, Belisle J, Morris S, Seder RA.
Infect Immun. 2003 Jan;71(1):575-9.

Journal of Virology
CD4 Binding Site Antibodies Inhibit Human Immunodeficiency Virus gp120 Envelope Glycoprotein Interaction with CCR5.
Raja A, Venturi M, Kwong P, Sodroski J.
J Virol. 2003 Jan 1;77(1):713-718.

Journal of Virology
Overcoming Immunity to a Viral Vaccine by DNA Priming before Vector Boosting.
Yang ZY, Wyatt LS, Kong WP, Moodie Z, Moss B, Nabel GJ.
J Virol. 2003 Jan 1;77(1):799-803.

Nature Medicine
Beyond six colors: A new era in flow cytometry.
De Rosa SC, Brenchley JM, Roederer M.
Nat Med 2003 Jan;9(1):112-7.

Handbook of Cell Signaling
HIV-1 Receptor Interactions.
Kwong PD.
Handbook of Cell Signaling, (Eds. Bradshaw RA and Dennis EA, Elsevier Adademic Press).

back to top


Highlights

The Quest for an Effective HIV Vaccine Presents New Possibilities, Challenges
May 16, 2007

Statement of Margaret I. Johnston, Ph.D., Gary J. Nabel, M.D., Ph.D., and Anthony S. Fauci, M.D., on HIV Vaccine Awareness Day
May 14, 2007

Scientists Unveil Piece of HIV Protein that May Be Key to AIDS Vaccine Development
Feb. 14, 2007

Learn how to become a VRC Clinical Trials volunteer

 
E-mail Icon E-mail this page
Print Icon Print this page


Highlights

The Quest for an Effective HIV Vaccine Presents New Possibilities, Challenges
May 16, 2007

Statement of Margaret I. Johnston, Ph.D., Gary J. Nabel, M.D., Ph.D., and Anthony S. Fauci, M.D., on HIV Vaccine Awareness Day
May 14, 2007

Scientists Unveil Piece of HIV Protein that May Be Key to AIDS Vaccine Development
Feb. 14, 2007

Learn how to become a VRC Clinical Trials volunteer